Development and validation of an LC-MS/MS method for ruxolitinib quantification: advancing personalized therapy in hematologic malignancies

Overview of attention for article published in Journal of Pharmacy and Pharmaceutical Sciences, June 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 1 X post from an account with 6,055 followers.

Development and validation of an LC-MS/MS method for ruxolitinib quantification: advancing personalized therapy in hematologic malignancies #JPPS https://t.co/NXG6Qy2fO9

15 Jul 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.